📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

GlaxoSmithKline PLC (G1SK34)

B3
Currency in BRL
Disclaimer
46.69
-0.11(-0.24%)
Delayed Data
G1SK34 Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
46.6946.85
52 wk Range
32.6050.15
Bid/Ask
46.60 / 46.90
Prev. Close
46.8
Open
46.78
Day's Range
46.69-46.85
52 wk Range
32.6-50.15
Volume
45
Average Volume (3m)
150
1-Year Change
32.98%
Fair Value
Unlock
Fair Value Upside
Unlock
G1SK34 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings downwards for the upcoming period
Show more

GlaxoSmithKline PLC Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees
70212
Market
Brazil

Compare G1SK34 to Peers and Sector

Metrics to compare
G1SK34
Peers
Sector
Relationship
P/E Ratio
16.3x19.9x−0.6x
PEG Ratio
−0.220.120.00
Price/Book
4.6x2.5x2.6x
Price / LTM Sales
2.1x3.6x3.1x
Upside (Analyst Target)
-8.8%57.2%
Fair Value Upside
Unlock9.3%7.3%Unlock

FAQ

What Is the GlaxoSmithKline (G1SK34) Stock Price Today?

The GlaxoSmithKline stock price today is 46.69.

What Stock Exchange Does GlaxoSmithKline Trade On?

GlaxoSmithKline is listed and trades on the B3 stock exchange.

What Is the Stock Symbol for GlaxoSmithKline?

The stock symbol for GlaxoSmithKline is "G1SK34."

Does GlaxoSmithKline Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 3.27%.

What Is the GlaxoSmithKline Market Cap?

As of today, GlaxoSmithKline market cap is 472.09B.

What is GlaxoSmithKline Earnings Per Share?

The GlaxoSmithKline EPS is 0.992.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.